From the food and drug administration: shock wave for heel pain
Henney
JAMA 284(21): 2711
2000
ISSN/ISBN: 0098-7484 PMID: 11105161 Document Number: 513123
Document emailed within 1 workday
Related Documents
Maier, M.; Steinborn, M.; Schmitz, C.; Stäbler, A.; Köhler, S.; Pfahler, M.; Dürr, H.R.; Refior, H.J. 2000: Extracorporeal shock wave application for chronic plantar fasciitis associated with heel spurs: prediction of outcome by magnetic resonance imaging Journal of Rheumatology 27(10): 2455-2462Adamek, H.E.; Sorg, S.; Bachor, O.A.; Riemann, J.F. 1995: Symptoms of post-extracorporeal shock wave lithotripsy: long-term analysis of gallstone patients before and after successful shock wave lithotripsy American Journal of Gastroenterology 90(7): 1125-1129
Garilevich, B.A.; Rotov, A.E.; Olefir, I.V. 2007: Pilot experience with administration of shock-wave therapy in the treatment of chronic prostatitis Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 3: 43-45
Zhang, L.; Tong, H.; Li, Y.-j.; Shan, Y.-x. 2015: Extracorporeal shock wave: An effective and safe therapy for the pain symptom of type IIIB prostatitis Zhonghua Nan Ke Xue 21(4): 325-329
Chopra, J.G. 1979: The role of Food and Drug Administration in food allergy Annals of Allergy 42(1): 1-4
Torra i Bou, J-Enric.; Rueda López, J.; Camañes, G.; Herrero Narváez, E.; Blanco Blanco, J.; Martínez-Esparza, E.Hernández.; Aneas Alcántara, Jús.; Verdú Soriano, Jé. 2002: Heel pressure ulcers. Comparative study between heel protective bandage and hydrocellular dressing with special form for the heel Revista de Enfermeria 25(5): 50-56
Fineberg, H.V. 2007: Reinventing the US Food and Drug Administration Medgenmed: Medscape General Medicine 9(2): 6
Smart, T. 1996: Delavirdine dilemma at the FDA. Food and Drug Administration Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 10(12): 4-5
Henney 2000: From the food and drug administration: new inhaled corticosteroid JAMA 284(13): 1640
Minno, A.M. 1972: A physicians's viewpoint. The Food and Drug Administration Pennsylvania Medicine 75(7): 61-62
Rajkumar, P.; Schmitgen, G.F. 2002: Shock waves do more than just crush stones: extracorporeal shock wave therapy in plantar fasciitis International Journal of Clinical Practice 56(10): 735-737
Tahara, H.; Katoh, Y.; Yano, H.; Kanbara, N.; Kohri, K.; Kurita, T. 1993: Septic shock induced by extracorporeal shock wave lithotripsy treatment with percutaneous nephrostomy in 5 cases with urolithiasis Hinyokika Kiyo. Acta Urologica Japonica 39(12): 1119-1124
1991: Pre-approval inspections/investigations. Food and Drug Administration Journal of parenteral science and technology: a publication of the Parenteral Drug Association 45(1): 56-66
Mallory, D. 1991: International experts met at the United States Food and Drug Administration Immunohematology 7(2): 52
Yin, L. 1976: The role of the Food and Drug Administration in instrumentation today and in the future Journal of Reproductive Medicine 16(4): 184-186
Schwetz, B.A. 2001: U.S. Food and Drug Administration--a science-based regulatory agency Journal - Association of Official Analytical Chemists 84(1): 171-175
Cohen, M.H.; Johnson, J.R.; Pazdur, R. 2005: U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 12-19
Miller, H.I. 1982: Recombinant DNA as a paradigm of a new technology: its impact on regulation by the Food and Drug Administration Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 36(6): 248-250
Garfin, S.R.; Yuan, H.A. 1997: Food and Drug Administration regulation of spinal implant fixation devices Clinical Orthopaedics and Related Research 335: 32-38
Nightingale, S.L. 1989: From the Food and Drug Administration. Interferon alfa approved for Kaposi's sarcoma JAMA 261(3): 350